Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ambarella is a leading fabless semiconductor company that specializes in low-power, high-definition video compression and computer vision processors. Founded in 2004 and headquartered in Santa Clara, California, the company provides AI-powered system-on-chips (SoCs) for a wide range of applications, including automotive ADAS, electronic mirrors, and autonomous driving. In the healthcare and life sciences sector, Ambarella’s technology is a critical component in high-resolution medical imaging devices such as endoscopes, surgical cameras, and AI-driven patient monitoring systems. Their proprietary CVflow AI architecture enables real-time, edge-based image analysis, which supports diagnostic accuracy and operational efficiency in clinical settings. Ambarella is publicly traded on the NASDAQ under the symbol AMBA and serves a global customer base across the technology and medical device industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ambarella.